Public signalCompany raiseAuto-indexed · Unverified
Olema Pharmaceuticals, Inc. raised $250.0M
Olema Pharmaceuticals, Inc.· SAN FRANCISCO, US· Pharmaceuticals· Filed Dec 12, 2024
Olema Pharmaceuticals, Inc. reported raising capital. Based in SAN FRANCISCO, CALIFORNIA, US. First sale reported 2024-12-04. Automatically indexed from a public SEC EDGAR Form D filing. Details beyond the filing have not been verified.
Raised
$250.0M
Confidence90%
Raised
$250.0M
Investors
26
Jurisdiction
DELAWARE
On the record
- Location
- SAN FRANCISCO, US
- Sector
- Pharmaceuticals
- Record type
- Company raise
- Stage
- Reported raised
- Amount raised
- $250.0M
- Target amount
- $250.0M
- Filing date
- Dec 12, 2024
- Issuer type
- operating company
Gaps in the record
- Valuation and deal terms are not on the public record
- No company website on record
- Investors are not disclosed
- Not yet claimed or verified by the company
Filing details
- Jurisdiction of incorporation
- DELAWARE
- Industry group
- Pharmaceuticals
- Number of investors
- 26
- Includes non-accredited investors
- No
- Revenue range
- Decline to Disclose
- Total offering amount
- $250.0M
- Amendment
- No
People named on this filing
Officers, directors, managers and entities listed in the public filing.
Andrew Rappaport
Director
San Francisco, US
Cynthia Butitta
Director
San Francisco, US
Cyrus L. Harmon, Ph.D.
Director
San Francisco, US
David C. Myles, Ph.D.
Executive Officer
San Francisco, US
Gorjan Hrustanovic, Ph.D.
Director
San Francisco, US
Graham Walmsley, M.D., Ph.D.
Director
San Francisco, US
Ian Clark
Director
SOUTH SAN FRANCISCO, US
Naseem Zojwalla, M.D.
Executive Officer
San Francisco, US
Sandra Horning, M.D.
Director
San Francisco, US
Scott Garland
Director
San Francisco, US
Sean Bohen, M.D., Ph.D.
Director
San Francisco, US
Shane Kovacs
Executive Officer
San Francisco, US
Yi Larson
Director
San Francisco, US
Sources & provenance
“Operating company sold 249,999,225 USD under Reg D.”
View original filing (SEC EDGAR Form D)
Automatically indexed from SEC EDGAR Form D · filing dated Dec 12, 2024. Details beyond the filing have not been verified.
Tags
USCompanyPharmaceuticalsOver $100MCompany Raise
Are you associated with Olema Pharmaceuticals, Inc.?
This is an automatically discovered public record, not a verified company listing. Founders can claim it and replace inferred data with verified facts.
Claim this record